insights_auto
Why is AGIO down ४.०३%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २७.६०
arrow_downward
-४.०३%(-१.१६) 1D
US$ २७.६०
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर २०, १६:००:०० GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २८.०१
High
US$ २९.१४
Low
US$ २७.४३
Mkt. cap
१.६५ अरब
Avg. vol.
११.२८ लाख
Volume
७.७६ लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २३.०२
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २८.०१
High
US$ २९.१४
Low
US$ २७.४३
Mkt. cap
१.६५ अरब
Avg. vol.
११.२८ लाख
Volume
७.७६ लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २३.०२
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
The Motley Fool
·
१ घण्टा पहिले
If the S&P 500 Drops by 20%, I'm Buying These 3 ETFs Without Hesitation
Traders Union
·
१ घण्टा पहिले
Seventeen of the twenty largest S&P 500 drops began below the 200-day moving average, Ryan Detrick notes
24/7 Wall St.
·
१ घण्टा पहिले
Jim Cramer Says the Market “Sliced Right Through” His S&P 500 Target
TradingView
·
४ घण्टा पहिले
Stock Market Crash: Nasdaq, S&P 500 Suffer Worst Weekly Losses in Years
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc